Detail Information of Genetic Polymorphisms
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0278 Transporter Info | ||||
| Gene Name | SLC31A1 | ||||
| Protein Name | High affinity copper uptake protein 1 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Genetic Polymorphisms of DT (GPD) | |||||
| Genetic Polymorphism | rs10759637 | ||||
| Site of GPD | chr9:113262744 (GRCh38.p12) | ||||
| GPD Type | SNP | ||||
| Allele(s) in dbSNP | A>C | ||||
| Minor Allele Frequency | A=0.4908/2458 (Global) | ||||
| Genotype AC | Click to Show/Hide the Full List of Affected Drugs: 2 Drugs in Total | ||||
| Platinum compounds | N.A. | Non-Small-Cell Lung Carcinoma | Correlated with the decreased likelihood of overall survival in patients (compare with genotypes AA + CC) | [ 1] | |
| Platinum compounds | N.A. | Thrombocytopenia | Correlated with the increased severity of thrombocytopenia in patients (compare with genotypes AA + CC) | [ 1] | |
| Genetic Polymorphism | rs2233914 | ||||
| Site of GPD | chr9:113221260 (GRCh38.p12) | ||||
| GPD Type | SNP | ||||
| Allele(s) in dbSNP | G>A | ||||
| Minor Allele Frequency | A=0.2015/1009 (Global) | ||||
| Genotype AA | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
| Platinum compounds | N.A. | Non-Small-Cell Lung Carcinoma | Correlated with the decreased severity of drug toxicity in patients (compare with Genotypes AG + GG); Correlated with the increased likelihood of overall survival in patients (compare with genotypes AG + GG) | [ 1] | |
| Genetic Polymorphism | rs4979223 | ||||
| Site of GPD | chr9:113219836 (GRCh38.p12) | ||||
| GPD Type | SNP | ||||
| Allele(s) in dbSNP | A>C | ||||
| Minor Allele Frequency | A=0.4718/2363 (Global) | ||||
| Genotype AC | Click to Show/Hide the Full List of Affected Drugs: 2 Drugs in Total | ||||
| Platinum compounds | N.A. | Non-Small-Cell Lung Carcinoma | Correlated with the decreased likelihood of overall survival in patients (compare with genotypes AA + CC) | [ 1] | |
| Platinum compounds | N.A. | Thrombocytopenia | Correlated with the increased severity of thrombocytopenia in patients (compare with genotypes AA + CC) | [ 1] | |
| Genetic Polymorphism | rs7851395 | ||||
| Site of GPD | chr9:113240184 (GRCh38.p12) | ||||
| GPD Type | SNP | ||||
| Allele(s) in dbSNP | A>G | ||||
| Minor Allele Frequency | A=0.4934/2471 (Global) | ||||
| Genotype AA | Click to Show/Hide the Full List of Affected Drugs: 2 Drugs in Total | ||||
| Cisplatin | Drug Info | Non-Small-Cell Lung Carcinoma | Correlated with the increased overall survival in patients (compare with genotypes AG + GG) | [ 2] | |
| Carboplatin | Drug Info | Non-Small-Cell Lung Carcinoma | Correlated with the increased overall survival in patients (compare with genotypes AG + GG) | [ 2] | |
| Genetic Polymorphism | rs10981694 | ||||
| Site of GPD | chr9:113224129 (GRCh38.p12) | ||||
| GPD Type | SNP | ||||
| Allele(s) in dbSNP | T>G | ||||
| Minor Allele Frequency | G=0.1160/581 (Global) | ||||
| Allele G | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
| Cisplatin | Drug Info | Testicular Neoplasm | Irrelevant to the likelihood of ototoxicity in patients (compare with Allele T) | [ 3] | |
| Genotypes GG + GT | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
| Cisplatin | Drug Info | Non-Small-Cell Lung Carcinoma | Correlated with the increased severity of ototoxicity in patients (compare with Genotype TT) | [ 4] | |
| Genetic Polymorphism | rs10817464 | ||||
| Site of GPD | chr9:113230217 (GRCh38.p12) | ||||
| GPD Type | SNP | ||||
| Allele(s) in dbSNP | T>A / T>C | ||||
| Minor Allele Frequency | C=0.0946/474 (Global) | ||||
| Allele T | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
| Platinum compounds | N.A. | Non-Small-Cell Lung Carcinoma | Irrelevant to the likelihood of overall survival and progression-free survival in patients (compare with allele C) | [ 1] | |
| Genotypes CC + CT | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
| Platinum compounds | N.A. | Non-Small-Cell Lung Carcinoma | Correlated with the increased severity of drug toxicity, hematologic diseases, leukopenia and thrombocytopenia in patients (compare with Genotype TT) | [ 1] | |
| Genetic Polymorphism | rs4978536 | ||||
| Site of GPD | chr9:113220123 (GRCh38.p12) | ||||
| GPD Type | SNP | ||||
| Allele(s) in dbSNP | A>G | ||||
| Minor Allele Frequency | G=0.3051/1528 (Global) | ||||
| Genotypes AG + GG | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
| Platinum compounds | N.A. | Non-Small-Cell Lung Carcinoma | Correlated with the increased severity of thrombocytopenia in patients (compare with genotype AA) | [ 1] | |
| References | |||||
| 1 | Genetic polymorphism of SLC31A1 is associated with clinical outcomes of platinum-based chemotherapy in non-small-cell lung cancer patients through modulating microRNA-mediated regulation. Oncotarget. 2018 May 8;9(35):23860-23877. | ||||
| 2 | Genetic polymorphism of copper transporter protein 1 is related to platinum resistance in Chinese non-small cell lung carcinoma patients. Clin Exp Pharmacol Physiol. 2012 Sep;39(9):786-92. | ||||
| 3 | Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular Cancer. JAMA Oncol. 2017 Nov 1;3(11):1558-1562. | ||||
| 4 | Prediction of copper transport protein 1 (CTR1) genotype on severe cisplatin induced toxicity in non-small cell lung cancer (NSCLC) patients. Lung Cancer. 2012 Aug;77(2):438-42. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.